You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

List of Excipients in API linaclotide

✉ Email this page to a colleague

« Back to Dashboard

Excipients in NDA-approved (novel) drugs containing linaclotide

Subscribe to access the full database, or Subscribe
Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Allergan Inc	LINZESS	linaclotide	0456-1201	CALCIUM CHLORIDE
Allergan Inc	LINZESS	linaclotide	0456-1201	CELLULOSE, MICROCRYSTALLINE
Allergan Inc	LINZESS	linaclotide	0456-1201	GELATIN
>Company	>Tradename	>Ingredient	>NDC	>Excipient	>Potential Generic Entry

Detailed excipient profiles for linaclotide

Excipient focus: CALCIUM CHLORIDE

linaclotide drug variants containing CALCIUM CHLORIDE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Allergan Inc	linaclotide	0456-1201
>Company	>Ingredient	>NDC

linaclotide drug variants not containing CALCIUM CHLORIDE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: CELLULOSE, MICROCRYSTALLINE

linaclotide drug variants containing CELLULOSE, MICROCRYSTALLINE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Allergan Inc	linaclotide	0456-1201
>Company	>Ingredient	>NDC

linaclotide drug variants not containing CELLULOSE, MICROCRYSTALLINE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: GELATIN

linaclotide drug variants containing GELATIN

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Allergan Inc	linaclotide	0456-1201
>Company	>Ingredient	>NDC

linaclotide drug variants not containing GELATIN

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: HYPROMELLOSE

linaclotide drug variants containing HYPROMELLOSE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Allergan Inc	linaclotide	0456-1201
>Company	>Ingredient	>NDC

linaclotide drug variants not containing HYPROMELLOSE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: LEUCINE

linaclotide drug variants containing LEUCINE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Allergan Inc	linaclotide	0456-1201
>Company	>Ingredient	>NDC

linaclotide drug variants not containing LEUCINE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: TITANIUM DIOXIDE

linaclotide drug variants containing TITANIUM DIOXIDE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Allergan Inc	linaclotide	0456-1201
>Company	>Ingredient	>NDC

linaclotide drug variants not containing TITANIUM DIOXIDE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.